Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of IV Tedizolid in Morbidly Obese vs Non-Obese Adults
NCT02342418Phase 4Completed
- Sponsor
- Amit.Pai
- Start
- Mar 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of tedizolid in acute bacterial skin and skin structure infection (ABSSSI) (2 arms), sponsored by Amit.Pai. Primary endpoint: Area Under the Concentration Time-curve From Time 0 to 72 Hours. Started Mar 2015; status: completed.
02
Drugs
tedizolid
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT02342418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342418.